Showing 1241-1250 of 7668 results for "".
- AAD, Other Major Medical Associations Support March For Sciencehttps://practicaldermatology.com/news/aad-other-major-medical-associations-support-march-for-science/2458214/The American Academy of Dermatology is joining up with many leading organizations in support of the March for Science and its nonpartisan call for the appreciation of scientific evidence, education, and investment. There are close to 400 marches and rallies in 37 countries scheduled to take place …
- RxPhoto Releases Updated HIPPA-Compliant Mobile Clinical Photography Apphttps://practicaldermatology.com/news/rxphoto-releases-updated-mobile-hippa-compliant-clinical-photo-app/2458213/RxPhoto has released version 3 of its mobile medical photography solution for medical practices and providers. Medical practices can now remain HIPAA compliant while using their mobile devices to securely capture, manage and share medical photos and videos. RxPhoto helps providers increase patient…
- Topical Cannabinoids May Soothe Itchy Skinhttps://practicaldermatology.com/news/topical-cannabinoids-may-soothe-itchy-skin/2458218/Cannabinoids contain anti-inflammatory properties that may make them useful in the treatment of a wide-range of skin diseases including eczema, psoriasis, atopic and contact dermatitis, according to researchers at the University of Colorado Anschutz Medical Campus. The new study appears in the Jo…
- ThermiGen, an Almirall company, Names Vladimir Paul-Blanc President & General Managerhttps://practicaldermatology.com/news/thermigen-an-almirall-company-names-vladimir-paul-blanc-president-general-manager/2458219/Vladimir Paul-Blanc has been named President & General Manager of ThermiGen, LLC, starting May 1. He will report directly to the Executive Vice-president of Commercial Strategy of Almirall, Alfonso Ugarte, and he will be responsible for all general management responsibilities for the Thermi busines…
- Maria Carell Named New CEO of Revision Skincare LLC, Goodier Cosmetics LLChttps://practicaldermatology.com/news/maria-carell-named-new-ceo-of-revision-skincare-llc-goodier-cosmetics-llc/2458223/Maria Carell is the new CEO of Revision Skincare® LLC and Goodier Cosmetics LLC. Ms. Carell's appointment follows the retirement of John Muller, the company's founder. Mr. Muller will retain his position on the Revision-Goodier board of directors as part of the transition of leadership and will …
- Scary Findings About Common Dermatologic Features of Classic Movie Villainshttps://practicaldermatology.com/news/study-ids-scary-findings-about-common-dermatologic-features-of-classic-movie-villains/2458227/What makes a villain (besides malice)? Scars, warts, deep wrinkles and alopecia, according to a new study that sought to identify the common dermatologic features of classic movie villains including Dr. Hannibal Lecter (“The Silence of the Lambs,” 1991), Mr. Potter (“It’s a Wonderful Life,” 1947) …
- Merz Taps Bob Rhatigan as New President, CEOhttps://practicaldermatology.com/news/merz-taps-bob-rhatigan-as-new-president-ceo/2458229/Allergan vet Bob Rhatigan is the new President and Chief Executive Officer (CEO) of Merz North America, and Patrick Urban will serve as Chief Commercial Officer, effective immediately. In his new role, Mr. Rhatigan will assume responsibility for Merz’s business in North America, leading strategy a…
- Apax Partners To Acquire Syneron for Close to $400 millionhttps://practicaldermatology.com/news/apax-partners-to-acquire-syneron-for-close-to-400-million/2458230/An affiliate of funds advised by Apax Partners will acquire all of the outstanding shares of Syneron Candela for $11.00 per share in cash in a transaction valued at approximately $397 million. The per share acquisition price represents a 15 percent premium to Syneron Candela's 90-day volume-weight…
- FDA Approves Addition of Moderate to Severe Fingernail Psoriasis Data to Humira Prescribing Informationhttps://practicaldermatology.com/news/fda-approves-addition-of-moderate-to-severe-fingernail-psoriasis-data-to-humira-prescribing-information/2458232/The FDA approved the inclusion of moderate to severe fingernail psoriasis data in AbbVie's Humira (adalimumab) prescribing information for patients with moderate to severe chronic plaque psoriasis. Humira is the first biologic treatment with data on fingernail psoriasis in its US prescribing inform…
- Study: Severe Psoriasis More Common in Menhttps://practicaldermatology.com/news/severe-psoriasis-more-common-in-men/2458235/Severe psoriasis predominantly affects men, according to a new study in the American Journal of Clinical Dermatology. In the study of 5,438 Swedish psoriasis patients, women had significantly (p<0.001) lower median Psoriasis Area Severity Index (PASI) values than men (5.4 for women versus 7.3 for …